The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.9M data for 1.2M Compounds and 9.3K Targets. Of those, 1,352K data for 627K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

37 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery of small molecule integrin alphavbeta3 antagonists as novel anticancer agents.EBI
University of Southern California
Synthesis and biological evaluation of dimeric RGD peptide-paclitaxel conjugate as a model for integrin-targeted drug delivery.EBI
University of Southern California
Application of CoMFA and CoMSIA 3D-QSAR and docking studies in optimization of mercaptobenzenesulfonamides as HIV-1 integrase inhibitors.EBI
University of Southern California
Small molecule inhibitors of signal transducer and activator of transcription 3 (Stat3) protein.EBI
University of Southern California
Discovery of a novel series of inhibitors of lymphoid tyrosine phosphatase with activity in human T cells.EBI
University of Southern California
Synthesis, chiral high performance liquid chromatographic resolution and enantiospecific activity of a potent new geranylgeranyl transferase inhibitor, 2-hydroxy-3-imidazo[1,2-a]pyridin-3-yl-2-phosphonopropionic acid.EBI
University of Southern California
Farnesyl pyrophosphate synthase enantiospecificity with a chiral risedronate analog, [6,7-dihydro-5H-cyclopenta[c]pyridin-7-yl(hydroxy)methylene]bis(phosphonic acid) (NE-10501): Synthetic, structural, and modeling studies.EBI
University of Southern California
Design, synthesis, and estrogenic activity of a novel estrogen receptor modulator--a hybrid structure of 17beta-estradiol and vitamin E in hippocampal neurons.EBI
University of Southern California
Structure-based virtual screening for plant-based ERbeta-selective ligands as potential preventative therapy against age-related neurodegenerative diseases.EBI
University of Southern California
Discovery of novel small-molecule inhibitors of human epidermal growth factor receptor-2: combined ligand and target-based approach.EBI
University of Southern California
A highly efficient route to enantiomerically pure l-N-Bz-Pmp(t-Bu)2-OH and incorporation into a peptide-based protein tyrosine phosphatase inhibitor.EBI
University of Southern California
Synthesis and biological evaluation of alpha-halogenated bisphosphonate and phosphonocarboxylate analogues of risedronate.EBI
University of Southern California
Inhibition of HIV-1 integrase activity by synthetic peptides derived from the HIV-1 HXB2 Pol region of the viral genome.EBI
University of Southern California
-Methylpropargylamine-Conjugated Hydroxamic Acids as Dual Inhibitors of Monoamine Oxidase A and Histone Deacetylase for Glioma Treatment.EBI
University of Southern California
Diketo acid pharmacophore. 2. Discovery of structurally diverse inhibitors of HIV-1 integrase.EBI
University of Southern California
GPCR Agonist-to-Antagonist Conversion: Enabling the Design of Nucleoside Functional Switches for the AEBI
University of Southern California
Beta-diketo acid pharmacophore hypothesis. 1. Discovery of a novel class of HIV-1 integrase inhibitors.EBI
University of Southern California
Inhibition of lysosomal cysteine proteases by chrysotherapeutic compounds: a possible mechanism for the antiarthritic activity of Au(I).EBI
University of Southern California
Metal-dependent inhibition of HIV-1 integrase.EBI
University of Southern California
Development of a Potent and Specific FGFR4 Inhibitor for the Treatment of Hepatocellular Carcinoma.EBI
University of Southern California
Rigidification Dramatically Improves Inhibitor Selectivity for RAF Kinases.EBI
University of Southern California
Development of Alkyne-Containing Pyrazolopyrimidines To Overcome Drug Resistance of Bcr-Abl Kinase.EBI
University of Southern California
Discovery of a novel 5-carbonyl-1H-imidazole-4-carboxamide class of inhibitors of the HIV-1 integrase-LEDGF/p75 interaction.EBI
University of Southern California
Fragment-based discovery of 8-hydroxyquinoline inhibitors of the HIV-1 integrase-lens epithelium-derived growth factor/p75 (IN-LEDGF/p75) interaction.EBI
University of Southern California
Discovery of novel inhibitors of LEDGF/p75-IN protein-protein interactions.EBI
University of Southern California
Development of the next generation of HIV-1 integrase inhibitors: pyrazolone as a novel inhibitor scaffold.EBI
University of Southern California
Discovery of 3-acetyl-4-hydroxy-2-pyranone derivatives and their difluoridoborate complexes as a novel class of HIV-1 integrase inhibitors.EBI
University of Southern California
Quinolone 3-carboxylic acid pharmacophore: design of second generation HIV-1 integrase inhibitors.EBI
University of Southern California
Discovery of novel non-cytotoxic salicylhydrazide containing HIV-1 integrase inhibitors.EBI
University of Southern California
Discovery of structurally diverse HIV-1 integrase inhibitors based on a chalcone pharmacophore.EBI
University of Southern California
Substituted 2-pyrrolinone inhibitors of HIV-1 integrase.EBI
University of Southern California
Effects of rigidity on the selectivity of protein kinase inhibitors.EBI
University of Southern California
In-cell production of a genetically-encoded library based on the ?-defensin RTD-1 using a bacterial expression system.EBI
University of Southern California
Cyclotides, a versatile ultrastable micro-protein scaffold for biotechnological applications.EBI
University of Southern California
Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor.EBI
University of Southern California
Pharmacophore guided discovery of small-molecule human apurinic/apyrimidinic endonuclease 1 inhibitors.BDB
University of Southern California